ModernMedicine Resource Center More Topics


Watch this video to learn how Vitamin D may help prevent infections with atopic dermatitis.

Dermatoses & Skin Disorders Resource Center

Promising new treatments for rosacea and leishmaniasis are among the highlights of a Maui Derm conference session about new drugs in dermatology.
Dermatology Times editorial advisor, Elaine Siegfried, M.D., talks with Peter Lio, M.D., assistant professor of clinical dermatology and pediatrics at Northwestern University’s Feinberg School of Medicine, and private practice, Dermatology and Aesthetics of Wicker Park, Wicker Park, Chicago, about his interest in alternative medicine and the legitimacy and usefulness of certain techniques and therapies.
According to researchers, abnormalities in the skin barrier and in the immune system that characterize atopic dermatitis can be reversed by drugs that narrowly target the immune signaling proteins interleukin (IL)-4 and -13.
New topical and systemic medications are being developed specifically for atopic dermatitis (AD). New guidelines of care for the management of AD are being issued by the American Academy of Dermatology, and ongoing research in other areas may change the approach to AD management in the future. Meanwhile, strategies are needed to combat steroid phobia.
The bad news is that office visits for atopic dermatitis are on the rise; the good news is that the condition usually responds to topical therapy and vigilant skin care, according to a clinical report from the American Academy of Pediatrics.
An animal study published online Nov. 3 in the Journal of Clinical Investigation links skin sensitization, gastrointestinal inflammation and food allergy.
Results of a new study suggest the extent to which new ways of delivering dermatological services could improve outcomes and ease access to care.
Pediatric dermatologists say a renewed interest in studying atopic dermatitis treatments could mean exciting times for the millions of children who suffer with the quality-of-life-altering itch and more.
More than half of the psoriasis patients surveyed by the National Psoriasis Foundation (NPF) said their psoriasis was disfiguring. Seventy-three percent of the thousands of people who responded said they felt angry or frustrated about their psoriasis. And 59 percent reported psoriasis was a large problem in their everyday lives.
You are called to the emergency room to see an ill-looking, 13-year-old boy with a severe flare of his atopic dermatitis associated with fever, malaise, and chills, which started a week ago.